Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

Added 266 days ago (04.01.2021)
Authors: Tannir, N. M., Signoretti, S., Choueiri, T. K., McDermott, D. F., Motzer, R. J., Flaifel, A., Pignon, J.-C., Ficial, M., Frontera, O. A., George, S., Powles, T., Donskov, F., Harrison, M. R., Barthelemy, P., Tykodi, S. S., Kocsis, J., Ravaud, A., Rodriguez-Cid, J. R., Pal, S. K., Murad, A. M., Ishii, Y., Saggi, S. S., McHenry, M. B., Rini, B. I.
Read article